AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of SEK 2.13 trillion. The enterprise value is 2.39 trillion.

Market Cap	2.13T
Enterprise Value	2.39T

Important Dates

The last earnings date was Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	Feb 20, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.54B

Valuation Ratios

The trailing PE ratio is 27.32.

PE Ratio	27.32
Forward PE	n/a
PS Ratio	3.86
PB Ratio	5.16
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.00, with an EV/FCF ratio of 21.38.

EV / Earnings	30.67
EV / Sales	4.40
EV / EBITDA	13.00
EV / EBIT	17.80
EV / FCF	21.38

Financial Position

The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.77.

Current Ratio	0.90
Quick Ratio	0.69
Debt / Equity	0.77
Debt / EBITDA	1.70
Debt / FCF	2.84
Interest Coverage	10.16

Financial Efficiency

Return on equity (ROE) is 19.79% and return on invested capital (ROIC) is 11.73%.

Return on Equity (ROE)	19.79%
Return on Assets (ROA)	8.16%
Return on Invested Capital (ROIC)	11.73%
Return on Capital Employed (ROCE)	17.65%
Revenue Per Employee	5.85M
Profits Per Employee	827,294
Employee Count	94,300
Asset Turnover	0.53
Inventory Turnover	1.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.78% in the last 52 weeks. The beta is 0.25, so AstraZeneca's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-14.78%
50-Day Moving Average	1,463.28
200-Day Moving Average	1,549.63
Relative Strength Index (RSI)	51.23
Average Volume (20 Days)	480,698

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca had revenue of SEK 551.90 billion and earned 78.01 billion in profits. Earnings per share was 49.88.

Revenue	551.90B
Gross Profit	455.00B
Operating Income	136.61B
Pretax Income	93.28B
Net Income	78.01B
EBITDA	183.46B
EBIT	136.61B
Earnings Per Share (EPS)	49.88

Full Income Statement

Balance Sheet

The company has 54.15 billion in cash and 318.37 billion in debt, giving a net cash position of -264.22 billion.

Cash & Cash Equivalents	54.15B
Total Debt	318.37B
Net Cash	-264.22B
Net Cash Per Share	n/a
Equity (Book Value)	412.87B
Book Value Per Share	265.77
Working Capital	-30.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 131.37 billion and capital expenditures -19.43 billion, giving a free cash flow of 111.94 billion.

Operating Cash Flow	131.37B
Capital Expenditures	-19.43B
Free Cash Flow	111.94B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 82.44%, with operating and profit margins of 24.75% and 14.14%.

Gross Margin	82.44%
Operating Margin	24.75%
Pretax Margin	16.90%
Profit Margin	14.14%
EBITDA Margin	33.24%
EBIT Margin	24.75%
FCF Margin	20.28%

Dividends & Yields

This stock pays an annual dividend of 33.75, which amounts to a dividend yield of 2.42%.

Dividend Per Share	33.75
Dividend Yield	2.42%
Dividend Growth (YoY)	11.42%
Years of Dividend Growth	3
Payout Ratio	63.60%
Buyback Yield	-0.08%
Shareholder Yield	2.34%
Earnings Yield	3.66%
FCF Yield	5.25%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AstraZeneca has an Altman Z-Score of 3.08.

Altman Z-Score	3.08
Piotroski F-Score	n/a